Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.diabres.2021.109022 http://scihub22266oqcxt.onion/10.1016/j.diabres.2021.109022 34450248!8383474!34450248     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34450248&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Diabetes+Res+Clin+Pract 2021 ; 179 (?): 109022 Nephropedia Template TP {{tp|p=34450248|t=2021. Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes |pdf=|usr=}}{{34450248}} gab.com Text Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes JO: Diabetes Res Clin Pract http://www.kidney.de/pget.php?&tw=1&pmid=34450248 #FOAvip In patients with autoimmune diabetes no significant differences were observed in glucose control, expressed as time in range evaluated by continuous glucose monitoring comparing the 3 days after Sars-Cov2 vaccine with the 14 days preceding the vaccine. Twit Text FOAVip Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes ????Diabetes Res Clin Pract http://www.kidney.de/pget.php?&tw=1&pmid=34450248 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34450248 #FOAvip English Wikipedia <ref>{{Cite pmid|34450248}}</ref> Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes #MMPMID34450248 D'Onofrio L; Coraggio L; Zurru A; Carlone A; Mignogna C; Moretti C; Maddaloni E; Buzzetti R Diabetes Res Clin Pract 2021[Sep]; 179 (?): 109022 PMID34450248show ga In patients with autoimmune diabetes no significant differences were observed in glucose control, expressed as time in range evaluated by continuous glucose monitoring comparing the 3 days after Sars-Cov2 vaccine with the 14 days preceding the vaccine. |*COVID-19[MESH] |*Diabetes Mellitus, Type 1/drug therapy[MESH] |Blood Glucose[MESH] |Blood Glucose Self-Monitoring[MESH] |Glucose[MESH] |Humans[MESH] |RNA, Viral[MESH] |SARS-CoV-2[MESH]Short-term safety profile of Sars-Cov2 vaccination on glucose control:(epmc).pdf DeepDyve Pubget Overpricing